@article{3aa49f1ecea64429833f18c89eefc8e0,
title = "Exploration of Oxygen-Induced Retinopathy Model to Discover New Therapeutic Drug Targets in Retinopathies",
keywords = "R-Ras, angiogenesis, diabetic retinopathy, filamin, hypoxia, myosin, retinopathy of prematurity (ROP), vascular permeability, R-Ras, angiogenesis, diabetic retinopathy, filamin, hypoxia, myosin, retinopathy of prematurity (ROP), vascular permeability",
author = "Maria V{\"a}h{\"a}tupa and J{\"a}rvinen, \{Tero A. H.\} and Hannele Uusitalo-J{\"a}rvinen",
note = "Funding Information: This study was supported by Academy of Finland, Finnish Diabetic Research Foundation, Diabetes Wellness Foundation, Tampere Tuberculosis Foundation, Pirkanmaa Hospital District Research Foundation, Finnish Eye Foundation, Finnish Cultural Foundation, Mary and Georg C. Ehrnrooth's Foundation, P?ivikki and Sakari Sohlberg Foundation and Tays Research Foundation. Publisher Copyright: {\textcopyright} Copyright {\textcopyright} 2020 V{\"a}h{\"a}tupa, J{\"a}rvinen and Uusitalo-J{\"a}rvinen.",
year = "2020",
doi = "10.3389/fphar.2020.00873",
language = "English",
volume = "11",
pages = "873",
journal = "FRONTIERS IN PHARMACOLOGY",
issn = "1663-9812",
publisher = "Frontiers Media S.A.",
}
